Jubir PDIP Guntur Romli menyebut bahwa kader PDIP tidak memberikan kado kepada namun merayakan ulang tahun Ketum PDIP dengan ...

ilustrasi bouquet bunga anggrek sebagai kado valentine (pexels.com/Vinícius Estevão) IDN Times Community adalah media yang menyediakan platform untuk menulis. Semua ...

The notice offers Vanda an opportunity to request a hearing on the matter. Also Read: Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst In ...

After a series of strongly worded letters—one of which was addressed directly to Commissioner Robert Califf—the FDA has publicly laid out its reasoning for rejecting Vanda Pharmaceuticals’ ...

The FDA met resistance from a three-judge panel Wednesday over its decision to refuse approval of Vanda Pharmaceuticals Inc.’s jet lag disorder drug. At issue in arguments before the US Court of ...

Rarely does the FDA pub­licly re­lease its rea­son­ing for re­ject­ing a po­ten­tial new drug. But for DC-based Van­da Phar­ma­ceu­ti­cals’ gas­tro­pare­sis drug, the FDA on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Nah, keajaiban dari Rinjani tidak berhenti di situ saja. Banyak pengunjung yang tidak tahu bahwa Rinjani juga rumah bagi berbagai flora dan fauna endemik, seperti anggrek vanda lombokensis dan burung ...

Penemuan ini mencakup spesies anggrek dari Indonesia, seperti Dendrobium cokronagoroi, Mediocalcar gemma-coronae, dan Dendrobium wanmae. Beberapa spesies tersebut bahkan sudah dinyatakan terancam ...

After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, M.D., is calling out the regulatory agency for a “disturbing pattern ...

Vanda called the attention of FDA Commissioner Robert Califf to what it termed the “sentiment that the agency avoids public scrutiny of its decisions.” Vanda Pharmaceuticals on Wednesday sent a letter ...

WASHINGTON, Jan. 8, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Logo (PRNewsfoto/Vanda ...